PTX3, Pentraxins, Immunology, Inflammation and Molecular biology are his primary areas of study. Giuseppe Peri interconnects Cohort study, Pathology, Sepsis, Intensive care medicine and Serum amyloid P component in the investigation of issues within PTX3. His Pentraxins research is multidisciplinary, incorporating perspectives in Septic shock, Intensive care unit, Critically ill and Cell biology.
The Immunology study combines topics in areas such as Peptide sequence and Gene family. His studies in Inflammation integrate themes in fields like Synovial Cell and Cytokine. His research integrates issues of Tumor necrosis factor alpha, Gene expression, Chemotaxis, Monocyte and Signal peptide in his study of Molecular biology.
Giuseppe Peri mainly investigates PTX3, Immunology, Internal medicine, Molecular biology and Pentraxins. The various areas that he examines in his PTX3 study include Proinflammatory cytokine, Innate immune system, Serum amyloid P component and Cell biology. His Immunology research integrates issues from Cytolysis and Cytotoxicity.
He focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Endocrinology and, in certain cases, Acute-phase protein. His research in Molecular biology intersects with topics in Tumor necrosis factor alpha, B cell, Peripheral blood mononuclear cell, Monocyte and Monoclonal antibody. His studies deal with areas such as Dendritic cell and Antigen-presenting cell as well as Pentraxins.
His primary areas of study are PTX3, Immunology, Internal medicine, Inflammation and C-reactive protein. Giuseppe Peri combines subjects such as Serum amyloid P component, Acute-phase protein, Cell biology, Proinflammatory cytokine and Innate immune system with his study of PTX3. His work deals with themes such as Tumor necrosis factor alpha, Cytokine and Vasospasm, Subarachnoid hemorrhage, which intersect with Proinflammatory cytokine.
His Sepsis study in the realm of Immunology interacts with subjects such as Pediatric leukemia. His Internal medicine research incorporates themes from Gastroenterology, Endocrinology and Cardiology. His research integrates issues of Interferon gamma, Pathogenesis and Mycobacterium tuberculosis in his study of Inflammation.
Giuseppe Peri mostly deals with PTX3, Innate immune system, Cell biology, Inflammation and Immunology. His PTX3 research is included under the broader classification of Internal medicine. His work in Innate immune system addresses issues such as Complement system, which are connected to fields such as Serum amyloid P component, Biochemistry, Glycosidic bond and Plasma protein binding.
The various areas that Giuseppe Peri examines in his Cell biology study include Endothelial stem cell, Angiogenesis, Growth factor and Autocrine signalling. His study in the fields of Acute-phase protein under the domain of Inflammation overlaps with other disciplines such as Vascular smooth muscle. His Immunology research is multidisciplinary, relying on both Shock and Intensive care.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response
Cecilia Garlanda;Emilio Hirsch;Silvia Bozza;Antonietta Salustri.
Nature (2002)
The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps
Sébastien Jaillon;Giuseppe Peri;Yves Delneste;Isabelle Frémaux.
Journal of Experimental Medicine (2007)
Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component.
F Breviario;E M d'Aniello;J Golay;G Peri.
Journal of Biological Chemistry (1992)
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction
Roberto Latini;Aldo P. Maggioni;Giuseppe Peri;Lucio Gonzini.
Circulation (2004)
PTX3, A Prototypical Long Pentraxin, Is an Early Indicator of Acute Myocardial Infarction in Humans
Giuseppe Peri;Martino Introna;Domenico Corradi;Giuseppe Iacuitti.
Circulation (2000)
Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 SIMILARITIES AND DIFFERENCES WITH THE SHORT PENTRAXINS C-REACTIVE PROTEIN AND SERUM AMYLOID P COMPONENT
Barbara Bottazzi;Valérie Vouret-Craviari;Antonio Bastone;Luca De Gioia.
Journal of Biological Chemistry (1997)
The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells.
Patrizia Rovere;Patrizia Rovere;Patrizia Rovere;Giuseppe Peri;Giuseppe Peri;Giuseppe Peri;Fausto Fazzini;Fausto Fazzini;Fausto Fazzini;Barbara Bottazzi;Barbara Bottazzi;Barbara Bottazzi.
Blood (2000)
Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients.
Beat Muller;Giuseppe Peri;Andrea Doni;Valter Torri.
Critical Care Medicine (2001)
Human pancreatic islets produce and secrete MCP-1/CCL2: Relevance in human islet transplantation
Lorenzo Piemonti;Biagio Eugenio Leone;Rita Nano;Alessandra Saccani.
Diabetes (2002)
Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells.
Nives Jonjić;Giuseppe Peri;Sergio Bernasconi;Francesca Luisa Sciacca.
Journal of Experimental Medicine (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Humanitas University
Humanitas University
Humanitas Research Hospital
Humanitas University
Vita-Salute San Raffaele University
Mario Negri Institute for Pharmacological Research
Humanitas University
Mario Negri Institute for Pharmacological Research
Humanitas University
Mario Negri Institute for Pharmacological Research
Pennsylvania State University
World Bank
University of Akron
Florida International University
Centre national de la recherche scientifique, CNRS
University of Haifa
International Centre for Genetic Engineering and Biotechnology
National Autonomous University of Mexico
Max Planck Society
Max Planck Society
University of Cambridge
University of Cincinnati
Osaka University
Seoul National University Hospital
Federal University of Toulouse Midi-Pyrénées
University of California, Los Angeles